CURIS INC (CRIS)

Latest Insider Confidence Score

2025Q4

50.0
Bearish

Company insider confidence (by quarter)

2004Q2 2025Q4

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Ra Capital Management, L.P. 10% Owner 6,250,564 Apr 17, 2008
RA Capital Healthcare Fund LP 10% Owner 6,250,564 Apr 17, 2008
Kolchinsky Peter 10% Owner 6,250,564 Apr 17, 2008
Aldrich Richard 10% Owner 6,250,564 Apr 17, 2008
RA Capital Biotech Fund II, L.P. 10% Owner 6,250,564 Apr 17, 2008

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
May 20, 2025 May 22, 2025 Dentzer James E CEO Neutral 52.5 - 0.00% ✗ -
May 20, 2025 May 22, 2025 Hohneker John Director Neutral 52.5 - 0.00% ✗ -
May 20, 2025 May 22, 2025 GREENACRE MARTYN D Director Neutral 52.5 - 0.00% ✗ -
May 20, 2025 May 22, 2025 Rubin Marc Director Neutral 52.5 - 0.00% ✗ -
May 20, 2025 May 22, 2025 Duvall Diantha CFO Neutral 52.5 - 0.00% ✗ -
May 20, 2025 May 22, 2025 Borgman Anne Elizabeth Director Neutral 52.5 - 0.00% ✗ -
May 20, 2025 May 22, 2025 Zung Jonathan B. CDO Neutral 52.5 - 0.00% ✗ -
May 20, 2025 May 22, 2025 KAITIN KENNETH I Director Neutral 52.5 - 0.00% ✗ -
May 1, 2025 May 5, 2025 Hamdy Ahmed MD CMO Neutral 52.5 - 0.00% ✗ -
May 5, 2025 Hamdy Ahmed MD CMO Neutral 52.5 - 0.00% ✗ -
Jan 28, 2025 Jan 30, 2025 Duvall Diantha CFO Neutral 52.5 - 0.00% ✗ -
Jan 28, 2025 Jan 30, 2025 Dentzer James E CEO Neutral 52.5 - 0.00% ✗ -
Jan 28, 2025 Jan 30, 2025 Zung Jonathan B. CDO Neutral 52.5 - 0.00% ✗ -
Jan 28, 2025 Jan 30, 2025 KAITIN KENNETH I Director Neutral 52.5 - 0.00% ✗ -
Jan 28, 2025 Jan 30, 2025 Rubin Marc Director Neutral 52.5 - 0.00% ✗ -
Jan 28, 2025 Jan 30, 2025 Borgman Anne Elizabeth Director Neutral 52.5 - 0.00% ✗ -
Jan 28, 2025 Jan 30, 2025 Hohneker John Director Neutral 52.5 - 0.00% ✗ -
Jan 28, 2025 Jan 30, 2025 GREENACRE MARTYN D Director Neutral 52.5 - 0.00% ✗ -
May 21, 2024 May 23, 2024 Duvall Diantha CFO Neutral 52.5 - 0.00% ✗ -
May 21, 2024 May 23, 2024 Dentzer James E CEO Neutral 52.5 - 0.00% ✗ -
May 21, 2024 May 23, 2024 Zung Jonathan B. CDO Neutral 52.5 - 0.00% ✗ -
May 21, 2024 May 23, 2024 KAITIN KENNETH I Director Neutral 52.5 - 0.00% ✗ -
May 21, 2024 May 23, 2024 Rubin Marc Director Neutral 52.5 - 0.00% ✗ -
May 21, 2024 May 23, 2024 Borgman Anne Elizabeth Director Neutral 52.5 - 0.00% ✗ -
May 21, 2024 May 23, 2024 Hohneker John Director Neutral 52.5 - 0.00% ✗ -
May 21, 2024 May 23, 2024 GREENACRE MARTYN D Director Neutral 52.5 - 0.00% ✗ -
May 1, 2023 May 3, 2023 Zung Jonathan B. CDO Neutral 52.5 - 0.00% ✗ -
May 3, 2023 Zung Jonathan B. CDO Neutral 52.5 - 0.00% ✗ -
Jan 23, 2023 Jan 24, 2023 KAITIN KENNETH I Director Neutral 52.5 - 0.00% ✗ -
Jan 23, 2023 Jan 24, 2023 Hohneker John Director Neutral 52.5 - 0.00% ✗ -
Jan 23, 2023 Jan 24, 2023 Rubin Marc Director Neutral 52.5 - 0.00% ✗ -
Jan 23, 2023 Jan 24, 2023 GREENACRE MARTYN D Director Neutral 52.5 - 0.00% ✗ -
Jan 23, 2023 Jan 24, 2023 Borgman Anne Elizabeth Director Neutral 52.5 - 0.00% ✗ -
Jan 20, 2023 Jan 24, 2023 Duvall Diantha CFO Neutral 52.5 - 0.00% ✗ -
Jan 20, 2023 Jan 24, 2023 Martell Robert Head of Research & Development Neutral 52.5 - 0.00% ✗ -
Jan 20, 2023 Jan 24, 2023 Dentzer James E CEO Neutral 52.5 - 0.00% ✗ -
Oct 12, 2022 Oct 14, 2022 Borgman Anne Elizabeth Director Neutral 52.5 - 0.00% ✗ -
Oct 14, 2022 Borgman Anne Elizabeth Director Neutral 52.5 - 0.00% ✗ -
Aug 10, 2022 Duvall Diantha CFO Neutral 52.5 - 0.00% ✗ -
Jan 31, 2022 Jan 31, 2022 Rubin Marc Director Neutral 52.5 - 0.00% ✗ -
Jan 31, 2022 Jan 31, 2022 Kunkel Lori Anne Director Neutral 52.5 - 0.00% ✗ -
Jan 31, 2022 Jan 31, 2022 KAITIN KENNETH I Director Neutral 52.5 - 0.00% ✗ -
Jan 31, 2022 Jan 31, 2022 Hohneker John Director Neutral 52.5 - 0.00% ✗ -
Jan 31, 2022 Jan 31, 2022 GREENACRE MARTYN D Director Neutral 52.5 - 0.00% ✗ -
Jan 29, 2022 Jan 31, 2022 Steinkrauss William CFO Neutral 52.5 - 0.00% ✗ -
Jan 29, 2022 Jan 31, 2022 Martell Robert Head of Research & Development Neutral 52.5 - 0.00% ✗ -
Jan 27, 2022 Jan 31, 2022 Dentzer James E CEO Sell 32.5 -5,500 -7.82% ✓ $17.1K
Dec 2, 2021 Dec 6, 2021 Hohneker John Director Neutral 52.5 - 0.00% ✗ -
Dec 6, 2021 Hohneker John Director Neutral 52.5 - 0.00% ✗ -
Jan 28, 2021 Jan 29, 2021 GREENACRE MARTYN D Director Neutral 52.5 - 0.00% ✗ -
Jan 28, 2021 Jan 29, 2021 Martell Robert Head of Research & Development Neutral 52.5 - 0.00% ✗ -
Jan 28, 2021 Jan 29, 2021 Rubin Marc Director Neutral 52.5 - 0.00% ✗ -
Jan 28, 2021 Jan 29, 2021 Steinkrauss William CFO Neutral 52.5 - 0.00% ✗ -
Jan 28, 2021 Jan 29, 2021 Dentzer James E CEO Neutral 52.5 - 0.00% ✗ -
Jan 28, 2021 Jan 29, 2021 Kunkel Lori Anne Director Neutral 52.5 - 0.00% ✗ -
Jan 28, 2021 Jan 29, 2021 KAITIN KENNETH I Director Neutral 52.5 - 0.00% ✗ -
Jan 25, 2021 Jan 26, 2021 Dentzer James E CEO Sell 32.5 -5,377 -7.40% ✓ $57.8K
Mar 2, 2020 Mar 4, 2020 KAITIN KENNETH I Director Neutral 52.5 - 0.00% ✗ -
Mar 2, 2020 Mar 4, 2020 Kunkel Lori Anne Director Neutral 52.5 - 0.00% ✗ -
Mar 2, 2020 Mar 4, 2020 Rubin Marc Director Neutral 52.5 - 0.00% ✗ -
Mar 2, 2020 Mar 4, 2020 GREENACRE MARTYN D Director Neutral 52.5 - 0.00% ✗ -
Mar 2, 2020 Mar 4, 2020 Steinkrauss William CFO Neutral 52.5 - 0.00% ✗ -
Mar 2, 2020 Mar 4, 2020 Martell Robert Head of Research & Development Neutral 52.5 - 0.00% ✗ -
Mar 2, 2020 Mar 4, 2020 Dentzer James E CEO Neutral 52.5 - 0.00% ✗ -
Jan 23, 2020 Jan 24, 2020 Dentzer James E CEO Sell 28.8 -6,752 -13.80% ✓ $11.3K
Sep 10, 2019 Sep 12, 2019 Steinkrauss William CFO Neutral 52.5 - 0.00% ✗ -
May 23, 2019 May 28, 2019 Dentzer James E CEO Neutral 52.5 - 0.00% ✗ -
May 23, 2019 May 28, 2019 Martell Robert Head of Research & Development Neutral 52.5 - 0.00% ✗ -
Apr 1, 2019 Steinkrauss William VP, Finance & Treasurer Neutral 52.5 - 0.00% ✗ -
Jan 23, 2019 Jan 25, 2019 Dentzer James E CEO Sell 30.0 -5,491 -11.65% ✓ $6.2K
Jan 23, 2019 Jan 25, 2019 Martell Robert Head of Research & Development Sell 13.8 -13,973 -37.76% ✓ $15K
Jan 23, 2019 Jan 25, 2019 GREENACRE MARTYN D Director Sell 13.8 -18,500 -41.49% ✓ $19.5K
Jan 23, 2019 Jan 25, 2019 Rubin Marc Director Sell 13.8 -18,500 -39.10% ✓ $19.5K
Jan 23, 2019 Jan 25, 2019 Kunkel Lori Anne Director Sell 13.8 -14,800 -40.00% ✓ $15.6K
Jan 23, 2019 Jan 25, 2019 KAITIN KENNETH I Director Sell 13.8 -14,800 -34.48% ✓ $15.6K
Jan 21, 2019 Jan 23, 2019 GREENACRE MARTYN D Director Neutral 52.5 - 0.00% ✗ -
Jan 21, 2019 Jan 23, 2019 KAITIN KENNETH I Director Neutral 52.5 - 0.00% ✗ -
Jan 21, 2019 Jan 23, 2019 Rubin Marc Director Neutral 52.5 - 0.00% ✗ -
Jan 21, 2019 Jan 23, 2019 Kunkel Lori Anne Director Neutral 52.5 - 0.00% ✗ -
Sep 26, 2018 Sep 27, 2018 Dentzer James E CEO Neutral 52.5 - 0.00% ✗ -
Jun 1, 2018 Jun 5, 2018 Martell Robert Head of Research & Development Neutral 52.5 - 0.00% ✗ -
May 15, 2018 May 17, 2018 Tuck David Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
May 15, 2018 May 17, 2018 Dentzer James E CFO Neutral 52.5 - 0.00% ✗ -
May 15, 2018 May 17, 2018 Fattaey Ali Ph.D. CEO Neutral 52.5 - 0.00% ✗ -
Jan 22, 2018 Jan 24, 2018 Martell Robert Director Neutral 90.0 +185,000 100.00% ✗ -
Jan 22, 2018 Jan 24, 2018 Kunkel Lori Anne Director Neutral 90.0 +185,000 100.00% ✗ -
Jan 22, 2018 Jan 24, 2018 Rubin Marc Director Neutral 90.0 +185,000 358.55% ✗ -
Jan 22, 2018 Jan 24, 2018 KAITIN KENNETH I Director Neutral 90.0 +185,000 624.85% ✗ -
Jan 22, 2018 Jan 24, 2018 GREENACRE MARTYN D Director Neutral 90.0 +185,000 487.55% ✗ -
Jan 22, 2018 Jan 24, 2018 Tuck David Chief Medical Officer Neutral 90.0 +133,750 374.92% ✗ -
Jan 22, 2018 Jan 24, 2018 Dentzer James E CFO Neutral 90.0 +206,250 3580.11% ✗ -
Jan 22, 2018 Jan 24, 2018 Fattaey Ali Ph.D. CEO Neutral 90.0 +206,250 177.97% ✗ -
Nov 16, 2017 Nov 16, 2017 Rubin Marc Director Buy 91.3 +25,000 94.00% ✗ $24.5K
Nov 15, 2017 Nov 15, 2017 Fattaey Ali Ph.D. CEO Buy 95.0 +50,000 75.88% ✗ $53K
May 31, 2017 Jun 2, 2017 GREENACRE MARTYN D Director Sell 26.3 -12,193 -24.32% ✗ $20.9K
May 31, 2017 Jun 2, 2017 KAITIN KENNETH I Director Sell 26.3 -12,193 -29.17% ✗ $20.9K
May 3, 2017 May 5, 2017 MCNAB JAMES R Director Sell 28.8 -76,276 -7.58% ✓ $155.4K
May 3, 2017 May 5, 2017 MCNAB JAMES R Director Sell 28.8 -76,276 -7.58% ✓ $155.4K
Apr 28, 2017 May 2, 2017 MCNAB JAMES R Director Sell 7.5 -116,708 -48.03% ✓ $278K
Apr 20, 2017 Apr 27, 2017 MCNAB JAMES R Director Sell 26.3 -110,322 -8.00% ✓ $285.7K